FDA Slashes Starting Dose for Lunesta

(MedPage Today) -- SILVER SPRING, Md. -- Patients starting on the sleep drug eszopiclone (Lunesta) should take no more than 1 mg at bedtime -- one-third the current label-recommended dose -- because of the risk of next-day impairment, the FDA said Thursday.
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news